title: Magnetic resonance imaging--insights into brain injury and outcomes in premature infants.
abstract: Preterm birth is a major public-health issue because of its increasing incidence combined with the frequent occurrence of subsequent behavioral, neurological, and psychiatric challenges faced by surviving infants. Approximately 10-15% of very preterm children (born<30 weeks gestational age) develop cerebral palsy, and 30-60% of them experience cognitive impairments. These adverse outcomes are related to a confluence of abnormal brain development along with white (WM) and gray matter (GM) injury sustained during the neonatal period. It is becoming apparent that the extra-uterine environment during this critical period (24-40 weeks gestation) in brain development has a profound and long lasting impact on the premature infant. Magnetic resonance imaging in the neonatal period and infancy provides a non-invasive, "in vivo" assessment of brain development and extent of brain injury. This not only helps understand the extent and timing of injury but also identifies infants who may benefit from early intervention to minimize the impact of the injury.
  
  
  OBJECTIVE
  Readers will be able to (1) appreciate the diverse impact of prematurity on neurodevelopmental outcome, (2) recognize the biological vulnerability of the developing brain in premature infants born between 24 and 40 weeks of gestation, (3) understand the role of magnetic resonance imaging (MRI) as a tool to detect abnormal development and brain injury in premature infants, and (4) see the potential role for novel MR imaging methods as biomarkers for brain development and injury in premature infants.
authors.affiliation: Division of Newborn Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA. mathur_a@wustl.edu
authors.forename: Amit
authors.initials: A
authors.lastname: Mathur
authors.forename: Terrie
authors.initials: T
authors.lastname: Inder
mesh_terms: D016880:Anisotropy; D015415:Biomarkers; D001921:Brain / Q000254:growth & development* / Q000473:pathology*; D001930:Brain Injuries / Q000209:etiology / Q000473:pathology*; D002540:Cerebral Cortex / Q000254:growth & development / Q000473:pathology; D002657:Child Development; D038524:Diffusion Magnetic Resonance Imaging; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature / Q000254:growth & development*; D007235:Infant, Premature, Diseases / Q000473:pathology*; D008279:Magnetic Resonance Imaging; D009413:Nerve Fibers, Myelinated / Q000473:pathology; D009929:Organ Size
chemical_list: D015415:Biomarkers